Can Urinary Leukotrienes and Thromboxanes Play the Role of New Prognostic Biomarkers of Recurring Restenosis in Patients With Peripheral Artery Occlusive Disease Undergoing Endovascular Treatment?
Maga, M., Wachsmann, A., Maga, P., Nizankowski, R.Volume:
27
Year:
2018
Journal:
Heart, Lung and Circulation
DOI:
10.1016/j.hlc.2018.06.1016
File:
PDF, 70 KB
2018